NewsWhore
10-18-2011, 05:40 PM
<img alt="" height="1" width="1" />
J&J Says FDA Seeks More Information on Fibrin Pad for Bleeding (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlrW6Y6TUQlMkHrOafzZywX6hZMg&url=http://www.bloomberg.com/news/2011-10-18/j-j-says-fda-seeks-more-information-on-fibrin-pad-for-bleeding.html)
Bloomberg
... down by generic competition for prescription drugs and costs related to its purchase of orthopedics company Synthes Inc. Boosted by favorable currency-exchange rates, sales climbed 6.8 percent to $16 billion, helping J&J top analysts' estimates. ...
and more » (http://news.google.com/news/more?ned=us&ncl=dkIjfgHObkzmvKM)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlrW6Y6TUQlMkHrOafzZywX6hZMg&url=http://www.bloomberg.com/news/2011-10-18/j-j-says-fda-seeks-more-information-on-fibrin-pad-for-bleeding.html)
J&J Says FDA Seeks More Information on Fibrin Pad for Bleeding (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlrW6Y6TUQlMkHrOafzZywX6hZMg&url=http://www.bloomberg.com/news/2011-10-18/j-j-says-fda-seeks-more-information-on-fibrin-pad-for-bleeding.html)
Bloomberg
... down by generic competition for prescription drugs and costs related to its purchase of orthopedics company Synthes Inc. Boosted by favorable currency-exchange rates, sales climbed 6.8 percent to $16 billion, helping J&J top analysts' estimates. ...
and more » (http://news.google.com/news/more?ned=us&ncl=dkIjfgHObkzmvKM)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFlrW6Y6TUQlMkHrOafzZywX6hZMg&url=http://www.bloomberg.com/news/2011-10-18/j-j-says-fda-seeks-more-information-on-fibrin-pad-for-bleeding.html)